Alts Watch Healthcare Beat: Nearly $1bn in fresh capital flows in latest life sciences deals

In numerical terms, our latest recon of private market investment in the life sciences is about on par with the previous week: 13 deals with a total value of $987 million.

But there was a noticeable difference on the focus of the deals. Drugmakers (mostly in the biotechnology space) took the lion's share of funding in our previous tallies, but this time much of the funding accrues to digital health . . .

Continue Reading

Unlock this article instantly, along with the rest of our premium content, newsletters and data tables tracking investor and manager activity. Monthly and annual subs available.

Get started

Sergio Barreto

Sergio Barreto is about 70% journalist, 30% tech geek. As an editor for The ABIS Group, he produces daily newsletters for leading healthcare and technology companies. With BMV Digital, he provides WordPress-based web developments services. Here at Alternatives Watch, he wears both hats - handling IT and occasionally writing about the intersection of alts, healthcare and tech.
Check Also
Close
Back to top button

Start Your Days in the Know

 

Get fresh alts intel in your inbox with our FREE newsletter!

You have Successfully Subscribed!